Erratum: Positive Feedback-Loop of Telomerase Reverse Transcriptase and 15-Lipoxygenase-2 Promotes Pulmonary Hypertension (PLoS ONE (2013) 8:12 (e83132) DOI: 10.1371/journal.pone.0083132);Positive feedback-loop of telomerase reverse transcriptase and 15-lipoxygenase-2 promotes pulmonary hypertension

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Shen, Tingting ^a   Ma, Jun ^a   Zhang, Lei ^a   Yu, Xiufeng ^a   Liu, Mengmeng ^a   Hou, Yunlong ^a   Wang, Yanyan ^a   Ma, Cui ^a   Li, Shuzhen ^a   Zhu, Daling ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXYICOSATETRAENOIC ACID; 15 LIPOXYGENASE 2; BROXURIDINE; MONOCROTALINE; OXYGENASE; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR PARAMETERS; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME MECHANISM; ENZYME REGULATION; FLOW CYTOMETRY; GENE SILENCING; HEART RIGHT VENTRICLE SYSTOLIC PRESSURE; HEART WEIGHT; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOPRECIPITATION; LUNG BLOOD VESSEL; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; POSITIVE FEEDBACK; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PULMONARY HYPERTENSION; PULMONARY VASCULAR DISEASE; PULMONARY VASCULAR REMODELING; RAT; SMOOTH MUSCLE FIBER; UPREGULATION;

ANIMALS; ANOXIA; ARACHIDONATE 15-LIPOXYGENASE; BLOOD PRESSURE; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; FEEDBACK, PHYSIOLOGICAL; GENE EXPRESSION REGULATION; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; HYPERTENSION, PULMONARY; MALE; MONOCROTALINE; MYOCYTES, SMOOTH MUSCLE; PROTEIN BINDING; PULMONARY ARTERY; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; TELOMERASE;

EID: 84893517693     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0308871     Document Type: Erratum

References (45)

1. Sahara M, Sata M, Morita T, Nakamura K, Hirata Y, et al. (2007) Diverse contribution of bone marrow-derived cells to vascular remodeling associated with pulmonary arterial hypertension and arterial neointimal formation. Circulation 115: 509-517. (Pubitemid 46184202)
2. Sitbon O, Lascoux-Combe C, Delfraissy JF, Yeni PG, Raffi F, et al. (2008) Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era. Am J Respir Crit Care Med 177: 108-113.
3. Humbert M, Sitbon O, Simonneau G (2004) Treatment of pulmonary arterial hypertension. N Engl J Med 351: 1425-1436.
4. D'Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, et al. (1991) Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 115: 343-349.
5. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, et al. (2010) Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation 122: 156-163.
6. Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, et al. (2004) Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 43: 13S-24S. (Pubitemid 38759713)
7. Jeffery TK, Wanstall JC (2001) Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension. Pharmacol Ther 92: 1-20. (Pubitemid 34032020)
8. Rabinovitch M (2008) Molecular pathogenesis of pulmonary arterial hypertension. J Clin Invest 118: 2372-2379.
9. Mathon NF, Lloyd AC (2001) Cell senescence and cancer. Nat Rev Cancer 1: 203-213. (Pubitemid 33741895)
10. Nakayama J, Saito M, Nakamura H, Matsuura A, Ishikawa F (1997) TLP1: a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell 88: 875-884. (Pubitemid 27164275)
11. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, et al. (1998) Extension of life-span by introduction of telomerase into normal human cells. Science 279: 349-352. (Pubitemid 28063364)
12. Minamino T, Kourembanas S (2001) Mechanisms of telomerase induction during vascular smooth muscle cell proliferation. Circ Res 89: 237-243. (Pubitemid 34132681)
13. Minamino T, Mitsialis SA, Kourembanas S (2001) Hypoxia extends the life span of vascular smooth muscle cells through telomerase activation. Mol Cell Biol 21: 3336-3342. (Pubitemid 32381769)
14. Bu DX, Johansson ME, Ren J, Xu DW, Johnson FB, et al. (2010) Nuclear factor {kappa}B-mediated transactivation of telomerase prevents intimal smooth muscle cell from replicative senescence during vascular repair. Arterioscler Thromb Vasc Biol 30: 2604-2610.
15. Nozaki Y, Liu T, Hatano K, Gharaee-Kermani M, Phan SH (2000) Induction of telomerase activity in fibroblasts from bleomycin-injured lungs. Am J Respir Cell Mol Biol 23: 460-465.
16. Tsujiuchi T, Tsutsumi M, Kido A, Takahama M, Sakitani H, et al. (1998) Induction of telomerase activity during regeneration after partial hepatectomy in the rat. Cancer Lett 122: 115-120. (Pubitemid 28058625)
17. Cao Y, Li H, Mu FT, Ebisui O, Funder JW, et al. (2002) Telomerase activation causes vascular smooth muscle cell proliferation in genetic hypertension. FASEB J 16: 96-98.
18. Zhao L, Funk CD (2004) Lipoxygenase pathways in atherogenesis. Trends Cardiovasc Med 14: 191-195. (Pubitemid 38942827)
19. Sigal E, Craik CS, Highland E, Grunberger D, Costello LL, et al. (1988) Molecular cloning and primary structure of human 15-lipoxygenase. Biochem Biophys Res Commun 157: 457-464. (Pubitemid 19021202)
20. Zhu D, Medhora M, Campbell WB, Spitzbarth N, Baker JE, et al. (2003) Chronic hypoxia activates lung 15-lipoxygenase, which catalyzes production of 15-HETE and enhances constriction in neonatal rabbit pulmonary arteries. Circ Res 92: 992-1000. (Pubitemid 36588498)
21. Ma J, Liang S, Wang Z, Zhang L, Jiang J, et al. (2010) ROCK pathway participates in the processes that 15-hydroxyeicosatetraenoic acid (15-HETE) mediated the pulmonary vascular remodeling induced by hypoxia in rat. J Cell Physiol 222: 82-94.
22. Ma C, Li Y, Ma J, Liu Y, Li Q, et al. (2011) Key role of 15-lipoxygenase/15-hydroxyeicosatetraenoic acid in pulmonary vascular remodeling and vascular angiogenesis associated with hypoxic pulmonary hypertension. Hypertension 58: 679-688.
23. Zhang L, Ma J, Shen T, Wang S, Ma C, et al. (2012) Platelet-derived growth factor (PDGF) induces pulmonary vascular remodeling through 15-LO/15-HETE pathway under hypoxic condition. Cell Signal 24: 1931-1939.
24. Zhou QG, Hu Y, Wu DL, Zhu LJ, Chen C, et al. (2011) Hippocampal telomerase is involved in the modulation of depressive behaviors. J Neurosci 31: 12258-12269.
25. Jeng KS, Sheen IS, Jeng WJ (2011) Azidothymidine treatment of hepatocellular carcinoma in rats: an in vivo study of telomerase inhibition. Hepatogastroenterology 58: 2091-2096.
26. Arteaga S, Andrade-Cetto A, Cardenas R (2005) Larrea tridentata (Creosote bush), an abundant plant of Mexican and US-American deserts and its metabolite nordihydroguaiaretic acid. J Ethnopharmacol 98: 231-239. (Pubitemid 40461975)
27. Guo L, Tang X, Tian H, Liu Y, Wang Z, et al. (2008) Subacute hypoxia suppresses Kv3.4 channel expression and whole-cell K+ currents through endogenous 15-hydroxyeicosatetraenoic acid in pulmonary arterial smooth muscle cells. Eur J Pharmacol 587: 187-195.
28. Maier KG, Henderson L, Narayanan J, Alonso-Galicia M, Falck JR, et al. (2000) Fluorescent HPLC assay for 20-HETE and other P-450 metabolites of arachidonic acid. Am J Physiol Heart Circ Physiol 279: H863-871.
29. Paterlini P, Suberville AM, Zindy F, Melle J, Sonnier M, et al. (1993) Cyclin A expression in human hematological malignancies: a new marker of cell proliferation. Cancer Res 53: 235-238. (Pubitemid 23031829)
30. Falchetti A, Franchi A, Bordi C, Mavilia C, Masi L, et al. (2005) Azidothymidine induces apoptosis and inhibits cell growth and telomerase activity of human parathyroid cancer cells in culture. J Bone Miner Res 20: 410-418. (Pubitemid 40293489)
31. Humer J, Ferko B, Waltenberger A, Rapberger R, Pehamberger H, et al. (2008) Azidothymidine inhibits melanoma cell growth in vitro and in vivo. Melanoma Res 18: 314-321.
32. Melana SM, Holland JF, Pogo BG (1998) Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by 3′-azido-3′- deoxythymidine. Clin Cancer Res 4: 693-696. (Pubitemid 28193570)
33. Mouraret N G-BG, Marcos E, Abid S, Amsellem V, Houssaïni A, et al. (2012) Progression of experimental hypoxic pulmonary hypertension is related to telomerase activity [abstract]. Am J Respir Crit Care Med 185: A5288.
34. Amsellem V, Gary-Bobo G, Marcos E, Maitre B, Chaar V, et al. (2011) Telomere dysfunction causes sustained inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 184: 1358-1366.
35. Liu K, Hodes RJ, Weng N (2001) Cutting edge: telomerase activation in human T lymphocytes does not require increase in telomerase reverse transcriptase (hTERT) protein but is associated with hTERT phosphorylation and nuclear translocation. J Immunol 166: 4826-4830. (Pubitemid 32280689)
36. Aisner DL, Wright WE, Shay JW (2002) Telomerase regulation: not just flipping the switch. Curr Opin Genet Dev 12: 80-85. (Pubitemid 34094994)
37. Forsythe HL, Jarvis JL, Turner JW, Elmore LW, Holt SE (2001) Stable association of hsp90 and p23, but Not hsp70, with active human telomerase. J Biol Chem 276: 15571-15574.
38. Thyberg J, Hedin U, Sjolund M, Palmberg L, Bottger BA (1990) Regulation of differentiated properties and proliferation of arterial smooth muscle cells. Arteriosclerosis 10: 966-990.
39. Anwar A, Li M, Frid MG, Kumar B, Gerasimovskaya EV, et al. (2012) Osteopontin is an endogenous modulator of the constitutively activated phenotype of pulmonary adventitial fibroblasts in hypoxic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 303: L1-L11.
40. Li P, Oparil S, Feng W, Chen YF (2004) Hypoxia-responsive growth factors upregulate periostin and osteopontin expression via distinct signaling pathways in rat pulmonary arterial smooth muscle cells. J Appl Physiol 97: 1550-1558; discussion 1549.
41. Zhu X, Kumar R, Mandal M, Sharma N, Sharma HW, et al. (1996) Cell cycle-dependent modulation of telomerase activity in tumor cells. Proc Natl Acad Sci U S A 93: 6091-6095. (Pubitemid 26190808)
42. Gizard F, Nomiyama T, Zhao Y, Findeisen HM, Heywood EB, et al. (2008) The PPARalpha/p16INK4a pathway inhibits vascular smooth muscle cell proliferation by repressing cell cycle-dependent telomerase activation. Circ Res 103: 1155-1163.
43. Tomlinson RL, Ziegler TD, Supakorndej T, Terns RM, Terns MP (2006) Cell cycle-regulated trafficking of human telomerase to telomeres. Mol Biol Cell 17: 955-965. (Pubitemid 43191127)
44. Landberg G, Nielsen NH, Nilsson P, Emdin SO, Cajander J, et al. (1997) Telomerase activity is associated with cell cycle deregulation in human breast cancer. Cancer Res 57: 549-554. (Pubitemid 27081678)
45. Ma J, Zhang L, Han W, Shen T, Ma C, et al. (2012) Activation of JNK/c-Jun is required for the proliferation, survival, and angiogenesis induced by EET in pulmonary artery endothelial cells. J Lipid Res 53: 1093-1105.